Cullinan Oncology, Inc. (CGEM) Tops Q3 EPS by 18c
Tweet
Share
E-mailGet Alerts CGEM Hot Sheet
Join SI Premium – FREE
Cullinan Oncology, Inc. (NASDAQ: CGEM) reported Q3 EPS of ($0.77), $0.18 better than the analyst estimate of ($0.95).
For earnings history and earnings-related data on Cullinan Oncology, Inc. (CGEM) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Paramount Weighs Tapping Musk For Equity Investment - Semafor
- Espey Manufacturing (ESP) Tops Q4 EPS by 24c
- Turkish Airlines orders 150 Boeing 737 MAX jets
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
